Sponsored by:

Molecular Imaging: Page 451

PharmaLogic P.E.T. Services receives PET nod
By AuntMinnie.com staff writers
PharmaLogic P.E.T. Services of Montreal has received approval from the Canadian government to begin selling its formulation of FDG.
February 3, 2008
SUVs need adjusting for high-resolution PET/CT
By Wayne Forrest
Radiologists and clinicians working with high-resolution PET/CT should adjust standardized uptake values (SUVs) accordingly to reduce the chance of errors in classifying head and neck tumors, according to researchers from the University of Minnesota in Minneapolis. In a recent study, the team found that maximum SUVs for head and neck lesions are significantly higher with high-resolution PET/CT than with conventional or lower-resolution systems.
January 31, 2008
BMS posts last financials for medical imaging business
By AuntMinnie.com staff writers
Pharmaceutical developer Bristol-Myers Squibb (BMS) has posted its 2007 fourth-quarter and year-end financial results, including results for the medical imaging division that it sold to venture capital firm Avista Capital Partners last month.
January 30, 2008
PET/CT shows value in head and neck tumors
By Brian Casey
January 30, 2008
GE partners with German firm on cancer therapeutics
By AuntMinnie.com staff writers
Multimodality vendor GE Healthcare of Chalfont St. Giles, U.K., has expanded a partnership with a German firm to include collaboration in the field of molecular imaging and its application to the development of cancer therapeutics.
January 30, 2008
Imaging set to play pivotal role for delivering molecular therapeutics
By Edward Susman
Treatment specialists experimenting with molecular medicine will achieve more targeted results by injecting drugs with imaging guidance, according to Dr. Lawrence Hoffmann, chief of interventional radiology at Stanford University Medical Center in California. In a recent presentation, Hofmann stressed that interventional oncology and interventional regenerative medicine will pair imaging and molecular therapeutics, as imaging plays a pivotal role in therapeutic angiogenesis.
January 30, 2008
False positives a concern with FDG-PET/CT for head, neck tumors
By Wayne Forrest
FDG-PET/CT is worthwhile for assessing patients with occult head and neck primary tumors, but false positives remain a shortcoming of the hybrid technology, according to a British study. The results show that FDG-PET/CT cannot replace examination under anesthesia and biopsies for assessing occult head and neck primary tumors.
January 30, 2008
2008 01 30 16 13 57 706
CIS-US gets clearance for generic Tc-99m mebrofenin kit
By AuntMinnie.com staff writers
Radiopharmaceutical manufacturer CIS-US has received clearance from the U.S. Food and Drug Administration Office of Generic Drugs to manufacture and market a generic kit for the preparation of technetium-99m (Tc-99m) mebrofenin.
January 29, 2008
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
January 27, 2008
Digirad to show new gamma camera at ACC '08
By AuntMinnie.com staff writers
Digirad of Poway, CA, plans to showcase a work-in-progress triple-head gamma camera at the annual meeting of the American College of Cardiology (ACC) in March.
January 24, 2008
FDA extends Cardiolite patent for pediatric use
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has extended the patent on Cardiolite for pediatric applications, effective January 8.
January 21, 2008
BioSphere names Weinstein to new post
By AuntMinnie.com staff writers
Interventional device developer BioSphere Medical of Rockland, MA, has named Joel B. Weinstein to the newly created position of vice president of global marketing and sales.
January 21, 2008
Previous Page
Page 451 of 620
Next Page